Exelixis Stock Price - EXEL

0.00 (0.0%)
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Exelixis Inc EXEL NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.00 0.0% 17.22 0.00 0.00 0.00 17.22 04:00:00
Bid Price Ask Price Spread Spread % News
15.51 20.99 5.48 26.11% - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 17.22 USD

Exelixis Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 5.26B 305.39M $ 690.07M 1.02 16.90 301.33M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Exelixis News

Date Time Source News Article
3/25/202003:01Business WireExelixis Announces Partner Takeda Receives Approval in Japan..
3/02/202016:11Edgar (US Regulatory)Current Report Filing (8-k)
3/02/202016:05Business WireExelixis Announces George A. Scangos, Ph.D. to Retire From..
2/26/202016:05Business WireExelixis Announces Webcasts of Investor Conference..
2/25/202016:15Edgar (US Regulatory)Annual Report (10-k)
2/25/202016:10Edgar (US Regulatory)Current Report Filing (8-k)
2/25/202016:06Business WireExelixis Announces First 100 Patients Enrolled in Phase 3..

Latest EXEL Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical EXEL Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week15.9918.16515.39516.662,658,3871.237.69%
1 Month19.2019.9313.6716.463,527,634-1.98-10.31%
3 Months18.5522.0613.6718.323,601,353-1.33-7.17%
6 Months17.7522.0613.6717.693,172,954-0.53-2.99%
1 Year23.9925.2013.6718.972,889,691-6.77-28.22%
3 Years21.6432.5013.4221.533,342,416-4.42-20.43%
5 Years2.5632.502.5115.404,015,14214.66572.66%

Exelixis Description

Exelixis is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its lead molecule cabozantinib is indicated for the treatment of patients with metastatic medullary thyroid cancer (as Cometriq) and advanced renal cell carcinoma, or kidney cancer, and hepatocellular carcinoma, or liver cancer (as Cabometyx). Exelixis and partner Roche have also brought Cotellic to market for the treatment of melanoma.
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200401 08:20:49